Andreas Haslinger

Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease1Preliminary parts of this study have been presented in abstract form at the 6th International Conference on Alzheimer's Disease and Related Disorders, July 18–23, 1998, Amsterdam, The Netherlands and at the 28th Annual Meeting of the Society for Neuroscience, November 7–12, 1998, Los Angeles, CA, USA.1

Harald Hampel, Stefan Teipel, Frank Padberg et al. · Brain Research · 1999 · 94 citations

Life Sciences, Neurology, Neuroscience +17

Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer’s disease brain

Harald Hampel, Andreas Haslinger, Michael Scheloske et al. · European Archives of Psychiatry and Clinical Neuroscience · 2004 · 67 citations

Life Sciences, Neurology, Neuroscience +17

Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls

Frank Padberg, Tom Nolde, Stefan Teipel et al. · Neuroscience Letters · 1999 · 66 citations

Medicine, Neurology, Neuroscience +14

Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130

Susanne Stübner, Tanja Schön, Frank Padberg et al. · Neuroscience Letters · 1999 · 62 citations

Nursing, Neuroscience, Psychiatry +12